Navigation Links
Reportlinker Adds Synthetic Biology: Emerging Global Markets Report
Date:9/3/2009

URE 16 BIOFUELS FEEDSTOCKS: RELATIVE COSTS AND VOLUMES 108

Sugars/Starches 108

Vegetable Oils 109

Biomass 109

Algae 109

TABLE 53 BIODIESEL YIELD OF SELECTED CROPS (GALS./ACRE/YR.) 109

CO2 110

CELLULOSIC ETHANOL INDUSTRY 111

TABLE 54 CELLULOSIC ETHANOL PLANTS (MGY) 111

Cellulosic Ethanol Industry (Continued) 112

BIOFUELS COMPETITOR STRATEGIES 113

TABLE 55 SYNTHETIC BIOLOGY-BASED BIOFUELS COMPANY STRATEGIES 114

TABLE 55 (CONTINUED) 115

Agrivida 115

Amyris 116

BP 116

DuPont 116

Gevo 116

LS9 117

Mascoma 117

OpX Biotechnologies 117

Sequesco 118

Solazyme 118

Synthetic Genomics 118

Verdezyne 118

Verenium 119

ROLE OF BIOFUELS FOUNDERS AND INVESTORS 119

TABLE 56 ROLE OF INVESTORS AND FOUNDERS IN BIOFUELS COMPANIES 119

ENZYMES INDUSTRY 120

TABLE 57 ENZYME COMPANY KEY ALLIANCES 121

PHARMACEUTICALS INDUSTRY 122

TABLE 58 PHARMACEUTICALS COMPANY STRATEGIES 122

INDUSTRY ACQUISITIONS AND STRATEGIC ALLIANCES 123

TABLE 59 INDUSTRY ACQUISITIONS, 2006-2008 123

TABLE 60 SYNTHETIC BIOLOGY STRATEGIC ALLIANCES, 2006-2009 124

TABLE 60 (CONTINUED) 125

TABLE 60 (CONTINUED) 126

BIODEFENSE ISSUES 127

TABLE 61 FUTURE SYNTHETIC BIOLOGY SECURITY REGULATIONS 127

SUPPORTING INDUSTRY ORGANIZATIONS 128

TABLE 62 SYNTHETIC BIOLOGY ENABLING ORGANIZATIONS 128

TABLE 62 (CONTINUED) 129

SUPPORTING INDUSTRY . . . (CONTINUED) 130

FIGURE 17 GROWTH IN IGEM (NUMBER) 131

Chapter-6: SYNTHETIC BIOLOGY MARKETS

GROWTH DRIVING FORCES 132

TABLE 63 SYNTHETIC BIOLOGY GROWTH DRIVING FORCES 133

FIGURE 18 NIH BUDGET OUTLAYS, 2000-2009 ($ BILLIONS) 134

FIGURE 19 SYNTHETIC BIOLOGY RESEARCH PUBLICATIONS, 2000-2008 (NUMBER
'/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Reportlinker Adds Smart Glass: Technologies and Global Markets Report
2. Swedish-American Life Science Summit (SALSS) to Address Major Issues Including Healthcare Reform, Synthetic Biology and Innovative Financing for Biotechs
3. Synthetic Genomics Inc. and ExxonMobil Research and Engineering Company Sign Exclusive, Multi-Year Agreement to Develop Next Generation Biofuels Using Photosynthetic Algae
4. Does Synthetic Biology Need Synthesized Ethics?
5. Synthetic Biology on the Rise
6. Pepscan Achieves a Breakthrough With CLIPS Immunogen Technology: Synthetic Peptide Antigen is Able to Induce Fully Functional Antibodies Against a Formerly Intractable GPCR Target CXCR7
7. Synthetic Biology: The Next Biotech Revolution Is Brewing
8. Synthetic Biology Importance in the 21st Century
9. RNAi Helps Illuminate the Inner Workings of the Cell Cycle: Synthetic RNAissance™ Genes Created by DNA2.0 Enable Key Research
10. The MathWorks Sponsors iGEM Competition for Synthetic Biology at MIT : MATLAB and SimBiology Help Accelerate Design of Synthetic Biological Systems
11. WuXi PharmaTech Promotes Dr. Rujian Ma to VP of Synthetic Chemistry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) ... today announced data from PERSIST-1 – a randomized Phase ... myelofibrosis – in a late-breaking oral session at the ... Clinical Oncology (ASCO), May 29-June 2, 2015 in ... oral multikinase inhibitor with specificity for JAK2 and FLT3. ...
(Date:5/30/2015)... CHICAGO and RARITAN, N.J. ... the international, multi-center, open-label, two-part, single-arm Phase 2 ... – an investigational, human anti-CD38 monoclonal antibody – ... percent (95% CI, 20.8-38.9), as assessed by an ... multiple myeloma. The ORR was consistent among the ...
(Date:5/30/2015)... 2015  Caris Life Sciences® today announced the ... researchers identified biomarker changes, including key driver mutations, ... changes in response to therapy as the disease ... subset of a larger study analyzing 1,245 glioma ... These data utilizing Caris Molecular Intelligence®, the company,s ...
(Date:5/29/2015)... HILL, N.C. , May 29, 2015 /PRNewswire/ ... medical affairs function into roles involving clinical development, ... As its responsibilities have grown, Medical Affairs has ... function as a global group. And while its ... find it challenging to identify strong performance metrics ...
Breaking Biology Technology:Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 2Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 3Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 4Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 5Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 6Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 7Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 8Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 9Phase 3 Pacritinib Study Shows Significant Clinically Meaningful Results In Patients With Myelofibrosis In Late-Breaking Session At ASCO 2015 10Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 2Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 3Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 4Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 5Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 6Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 7Caris Life Sciences Paired Tumor Data Identifies Key Driver Mutations and Confirms Tumor Heterogeneity in High-Grade Glioma Samples 2Caris Life Sciences Paired Tumor Data Identifies Key Driver Mutations and Confirms Tumor Heterogeneity in High-Grade Glioma Samples 3Caris Life Sciences Paired Tumor Data Identifies Key Driver Mutations and Confirms Tumor Heterogeneity in High-Grade Glioma Samples 4Creating an Effective Pharmaceutical Medical Affairs Group with Global Capabilities 2
... New Jersey, December 5, Rosetta Genomics, Ltd. (NASDAQ: ... as biomarkers,reported today its consolidated financial results for the ... The company recorded revenues ... were recorded from the date of acquisition of Parkway ...
... Sky One Medical,Inc. ("China Sky One Medical" or "the ... pharmaceutical company producing over-the-counter drugs in,the People,s Republic of ... and President of China Sky One Medical took part ... Perspective. , As ...
... today announced that David Hung, M.D., president and chief,executive officer, will be ... Conference on Thursday, December 11, in New York: , ... Eastern Time, -- "The Challenge of Alzheimer,s Disease" from ... A live audio webcast of each panel ...
Cached Biology Technology:Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 2Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 3Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 4Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 5Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 6Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 7Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 8Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 9Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS 10China Sky One Medical, Inc. Interviewed in The China Perspective 2China Sky One Medical, Inc. Interviewed in The China Perspective 3Medivation Announces Participation in RBC Capital Markets 2008 Healthcare Conference 2
(Date:5/14/2015)... and Markets ( http://www.researchandmarkets.com/research/5whpxg/fingerprint ) has announced ... Smart Mobile Devices " report to their offering. ... watershed year for fingerprint sensors in smartphones and tablets, ... fingerprint sensors a raison d,etre in the mobile milieu ... must-have feature in flagship smartphones. The key ...
(Date:5/11/2015)... , May 11, 2015  Through a well-rounded UAS ... had a strong showing at AUVSI,s Unmanned 2015 ... representatives of Ohio,s UAS industry met ... abroad from all points along the UAS ecosystem. ... Coalition,s (DDC) Vice President for Aerospace Rich Knoll . ...
(Date:5/8/2015)... May 8, 2015 Synaptics Inc. (NASDAQ: SYNA ... that members of the executive management team will present at ... Technology, Media and Telecom Conference Date: May 18, 2015 ... Boston, MA Cowen and Company ... 2:45pm ET Location: The New York Palace Hotel, ...
Breaking Biology News(10 mins):Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2Synaptics to Present at Upcoming Investor Conferences 2
... Wiley Interdisciplinary Reviews (WIREs), the pioneering new publications launched ... the most prestigious awards in scholarly publishing at the ... Professional & Scholarly Excellence (PROSE Awards) named the WIREs ... the association,s top prize, established in 1976 to recognise ...
... of Medicine believe they may have discovered how the ... The findings will be presented at the Annual Scientific ... Chicago by Errol Norwitz, M.D., professor in the Department ... Preterm birthdelivery prior to 37 weeks gestationhas become ...
... Eastern Illinois Foodbank shared results of a national study ... organization. The study is completed every four years by ... emergency food distribution throughout the United States. Craig Gundersen, ... Consumer Economics at the University of Illinois, is a ...
Cached Biology News:WIREs win 3 prizes at the PROSE awards 2U of I faculty assist in evaluating US food security programs 2
... A perfect complement to high-speed analytical techniques, the AutoTrace SPE is a powerful, ... the cartridge conditioning, sample loading and elution steps for large volumes aqueous solution ... ... ...
... optically clear polystyrene with frosted labeling ... for cell counting. 100% integrity tested. ... new product number, created to easily ... no availability yet, please order under ...
Cell Culture Flask, nontreated polystyrene...
... The Corning CellBIND surface is produced ... a more hydrophilic surface giving more consistent, ... yields. CellBIND enhances cell attachment and growth ... serum-free medium. • CellBIND may provide a ...
Biology Products: